https://www.labiotech.eu/trends-news/brainever-3p-biopharmaceuticals-developing-drug-hopes-cure-als/
0
0
11/15/22 at 8:38am
Organization
Labiotech.eu
Author
Jim Cornall
31 words
0
Comments
3P and BrainEver are to collaborate on developing hEng1, a recombinant homeoprotein, to treat ALS or Parkinson’s disease.
You are the first to view
Create an account
or login to join the discussion